Abstract
Early-pregnancy plasma lncRNAs and mRNAs are markedly dysregulated in PE and correlate with pathogenic pathways. Notably, lncRNAs with |log<sub>2</sub>FC| ≥ 5 and mRNAs with |log<sub>2</sub>FC| ≥ 6 may serve as novel biomarkers for early PE prediction.
Introduction
Preeclampsia (PE) remains a primary cause of maternal and fetal morbidity and mortality, affecting approximately 5–8% of pregnancies globally. Characterized by late-gestation hypertension and multi-organ dysfunction, the biological foundations of PE—including impaired placental development and systemic inflammation—are established much earlier in the first trimester. Currently, clinical diagnosis often occurs after significant damage has transpired, leaving delivery as the only definitive intervention. This study investigates the potential of cell-free long non-coding RNAs (lncRNAs) and mRNAs in early-pregnancy plasma (7–14 weeks) to serve as non-invasive biomarkers for early prediction and intervention.
Methods
A prospective cohort study was conducted in Tianjin, China, involving plasma samples from 16 pregnant women (8 who later developed PE and 8 normotensive controls) collected between 7 and 14 weeks of gestation.
- Transcriptome Sequencing: High-throughput sequencing of cell-free RNA was performed using the Illumina HiSeq 4000 platform.
- Bioinformatics Analysis: Differentially expressed transcripts (DETs) were identified using thresholds of $|fold change (FC)| \geq 2$ and $P \leq 0.05$.
- Functional Annotation: Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were utilized to identify enriched biological pathways.
- Network Construction: A lncRNA-mRNA co-expression network was developed to explore regulatory relationships between non-coding and protein-coding transcripts.
Results
Transcriptomic Profile and Dysregulation
The analysis revealed a significant shift in the plasma transcriptomic signature of women who subsequently developed PE. A total of 361 lncRNAs (171 upregulated, 190 downregulated) and 3,798 mRNAs (3,320 upregulated, 478 downregulated) were significantly dysregulated.
Extreme dysregulation was observed in several transcripts. For instance, the lncRNA ENST00000440816 showed a $log_2FC$ of +175.29, while the mRNA TEX35 was the most significantly upregulated protein-coding transcript ($log_2FC = +8.70$).
Distinct Molecular Signatures
Heatmap analysis demonstrated that the expression profiles of these transcripts could clearly distinguish between the PE and control groups during the first trimester.
Pathogenic Pathway Convergence
Dysregulated genes were significantly enriched in pathways critical to PE pathogenesis, including:
- PI3K-Akt and mTOR Signaling: Essential for trophoblast invasion and proliferation.
- NF-κB Signaling: Indicative of early systemic inflammatory responses.
- p53 Signaling: Suggesting early-onset programmed cell death (apoptosis) in placental tissues.
Co-expression analysis identified 17 specific lncRNAs as central hubs regulating 55 mRNAs, particularly those involved in oxidative stress and inflammation.
Discussion
The findings suggest that plasma lncRNA and mRNA signatures are stable and detectable long before clinical symptoms emerge. The authors propose high-confidence diagnostic thresholds: lncRNAs with $|log_2FC| \geq 5$ and mRNAs with $|log_2FC| \geq 6$ as potential biomarkers.
While promising, this study is limited by a small sample size ($n=16$) and requires validation in larger, multi-center cohorts. Furthermore, functional "wet lab" studies are necessary to establish causal links between these transcripts and placental defects. Nonetheless, this research provides a theoretical framework for developing first-trimester screening tools to improve PE management.
Summary updated